Status:
UNKNOWN
Indocyanine Green Clearance Test in Liver Transplantation (LivInG)
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborating Sponsors:
Azienda Policlinico Umberto I
Conditions:
Hepatic and Hepatobiliary Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The gap between patients awaiting and those undergoing liver transplantation (LT) continues to grow. Marginal organs carry higher risk of failure after LT however they are increasingly used to fill su...
Detailed Description
Liver transplantation (LT) is the gold standard treatment for end-stage liver diseases. The success of LT and the expansion of medical conditions that are successfully treated with LT, has caused a gr...
Eligibility Criteria
Inclusion
- All consecutive liver donors included in the study period
- All consecutive liver recipients transplanted in the study period from a donor tested with Indocyanine Green
Exclusion
- Donor or recipients history of allergy to hyodine.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT05228587
Start Date
February 1 2022
End Date
November 1 2024
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS
Roma, Italy, 00168